Happiness Development Group Limited Class A Ordinary Shares

Gainers CinCor Pharma, Inc. (NASDAQ: CINC) rose 140.2% to $28.30 in pre-market trading after AstraZeneca announced plans to buy the company for up to $1.8 billion. Amryt Pharma plc (NASDAQ: AMYT) shares rose 112% to $14.86 in pre-market trading after Chiesi Farmaceutici S.p.A. announced plans to acquire the company. Apexigen, Inc. (NASDAQ: APGN) rose 92.4% to $1.81 in pre-market trading after climbing more than 10% on Friday. Albireo Pharma, Inc. (NASDAQ: ALBO) shares rose 87.3% to $42.73 in pre-market trading. Bed Bath & Beyond Inc. (NASDAQ: BBBY) rose 53.4% to $2.01 in pre-market trading. Bed Bath & Beyond shares dropped over 22% on Friday following a report indicating the company could file for bankruptcy in the coming weeks. Party City Holdco Inc. (NYSE: PRTY) rose 28.4% to $0.23 in pre-market trading. Party City shares dropped 50% on Friday following a report suggesting the company has hired a restructuring advisor and plans a bankruptcy filing within weeks. Phathom Pharmaceuticals, Inc. (NASDAQ: PHAT) rose 24.8% to $9.39 in ...

Related tickers: VIRX, MULN, CINC, BBBY, APGN, NEPT, HOLO, LIXT, MLEC, PRTY, CRBP, ALBO, NVOS, HAPP, PHAT, AMYT, CVAC, VYNE, SPRB.

Gainers Crown ElectroKinetics Corp. (NASDAQ: CRKN) shares rose 153% to $0.3325 after gaining 14% on Tuesday. Crown ElectroKinetics, last month, posted a Q3 loss of $0.18 per share. Vallon Pharmaceuticals, Inc. (NASDAQ: VLON) shares jumped 140% to $0.6041 after the company entered into a definitive merger agreement with GRI Bio. Immix Biopharma, Inc. (NASDAQ: IMMX) jumped 46% to $2.1695 after the company announced it has in-licensed BCMA-targeted next-generation CAR-T therapy NXC-201 with 85% ORR and 71% CR/sCR at the therapeutic dose from the first 20 patients in an ongoing phase 1b relapsed/refractory multiple myeloma ongoing clinical trial. Senti Biosciences, Inc. (NASDAQ: SNTI) rose 45% to $2.09 after dipping more than 21% on Tuesday. Avidity Biosciences, Inc. (NASDAQ: RNA) shares climbed 44.3% to $15.84 after the company announced AOC 1001 data from the preliminary assessment of the Phase 1/2 MARINA trial demonstrating the first-ever successful targeted delivery of RNA into muscle. BIMI International Medical, Inc. (NASDAQ: BIMI) gained 28.1% to $2.6649. BIMI reported entry into a material definitive agreement for the acquisition of Wuzhou Qiangsheng Hospital Co., Ltd., Suzhou Eurasia Hospital Co., Ltd. and Yunan Yuxi Minkang Hospital Co., Ltd. Wave Life Sciences Ltd. (NASDAQ: WVE) gained 21.1% to $5.80. SVB Leerink maintained WAVE Life Sciences with a Market Perform and raised the price target from $2 to $7. Kymera Therapeutics, Inc. (NASDAQ: KYMR) shares gained 21.4% to $31.38 after the company announced results from the Phase 1 clinical trial evaluating KT-474 in patients with HS and AD and Sanofi's decision to advance KT-474 into Phase 2 clinical trials. Aspen Group, Inc. (NASDAQ: ASPU) gained 17.4% to $0.41 after reporting strong quarterly sales. REV Group, Inc. (NYSE: REVG) jumped 17.2% to $15.57 as the company reported a fourth-quarter FY22 sales growth ...

Related tickers: OPGN, KYMR, DFLI, WVE, KSPN, GETR, ZVSA, SFR, SIOX, CYTK, REVG, NVVE, HLIT, AVDL, NCPL, RBCN, NXL, PBLA, CHTR, CVNA, WNW, QTEK, PCSA, YMTX, SMMT, ASPU, VS, VINC, DYN, PHCF, VLON, RNA, HROW, LVTX, UIHC, SQL, BHG, SNTI, HAPP, BTB, BIMI, OCG, ARQQ, OTIC, BXRX, MULN, DS, CRKN, IMMX.